Skip to main content
Anxiety symptom screening

Generalized Anxiety Disorder 7-item

The GAD-7 is a brief self-report screen of anxiety symptom frequency over the past two weeks. This page explains the measure for clinics. It is not a test to complete here.

7 itemsAdult self-reportPast 2 weeksClinician reviewed

What is the GAD-7?

The Generalized Anxiety Disorder 7-item scale was developed by Spitzer, Kroenke, Williams and colleagues as a short self-report measure of anxiety symptom burden. Clinics use it for intake, review, and monitoring. It does not by itself establish an anxiety disorder diagnosis.

Development and clinical use

GAD-7 was introduced in the mid-2000s with a Pfizer educational grant and later became one of the most widely used brief anxiety measures in primary care and specialist services. The source form states that no permission is required to reproduce, translate, display, or distribute.

Source instrument
7 self-report items
Reference period
Past 2 weeks
Response format
4 frequency options
Respondent
Patient self-report
Typical use
Screening and monitoring
Clinical role
Screening support

A focused client experience

Respondents rate how often seven problems have bothered them over the past two weeks. Results are intended to support a clinician conversation about symptom burden, duration, impairment, and whether a fuller anxiety assessment is needed.

  • One question at a time with visible progress
  • Large keyboard-operable response choices
  • Previous, next, and answer-review steps
  • Clear confirmation that results go to the clinic
Client viewQuestion 3 of 7

Frequency choices are shown without reproducing GAD-7 item wording.

PreviousNext question

Designed to make evidence easy to review

Lirena's public pages show how response evidence would be laid out for a responsible clinician. This illustration uses no patient data and does not reproduce instrument questions.

  • Named instrument, version, and provenance
  • Item-level response pattern without source wording
  • Methodology, references, and clinical boundary
  • Responsible clinician review rather than automated conclusions
General clinic pathway
LLIRENASynthetic example
Generalized Anxiety Disorder 7-item
ReviewContextSource

Clinician review required

Understand the measure and its scoring conventions

Published source materials describe a 0-21 total and suggested screening bands. This public page does not independently verify scoring, cutoffs, or a production scoring rule. Use the official form and scoring instructions for the version you intend to use.

  1. Original GAD-7 validationSpitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092-1097.
  2. Official source formsPfizer Inc. Patient Health Questionnaire (PHQ) screeners.

What clinics ask before they evaluate the GAD-7

These answers stay inside educational catalogue scope. They do not replace official manuals, licences, or clinician judgement.

What is the GAD-7 used for?

Clinics use it as a short anxiety symptom screen and a way to track change. It structures how often the person has been bothered by named problems, then a clinician reviews the result in context.

Does a GAD-7 score diagnose anxiety?

No. It is a screening and severity measure. Diagnosis, differential diagnosis, and treatment decisions remain with the responsible clinician.

Can I complete GAD-7 on this page?

No. This is educational catalogue information and a product illustration. Lirena does not provide a public self-test or automated interpretation here.

Is permission required to use GAD-7?

The source form states that no permission is required to reproduce, translate, display, or distribute. Still confirm you are using the official form and that it fits your population and governance.

See how an anxiety measure would sit in clinic review.